title: Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma.
authors: Laurent
authors: L
authors: Arnaud
authors: Noël E C
authors: NE
authors: Schartz
authors: Guilhem
authors: G
authors: Bousquet
authors: Farid
authors: F
authors: Sarandi
authors: Olivier
authors: O
authors: Verola
authors: Isabelle
authors: I
authors: Madelaine
authors: Delphine
authors: D
authors: Kerob
authors: Céleste
authors: C
authors: Lebbe
mesh_terms: D000008:Abdominal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003128:Coma / Q000139:chemically induced*; D017809:Fatal Outcome; D005260:Female; D005350:Fibroma / Q000188:drug therapy* / Q000601:surgery; D005354:Fibrosarcoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects*; D000077210:Sunitinib; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D047428:Protein Kinase Inhibitors; D011758:Pyrroles; D011505:Protein-Tyrosine Kinases; D000077210:Sunitinib